These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17415283)

  • 1. Subcutaneous immune globulin (SCIG).
    Med Lett Drugs Ther; 2007 Apr; 49(1258):31-2. PubMed ID: 17415283
    [No Abstract]   [Full Text] [Related]  

  • 2. Nuts and Bolts of Subcutaneous Therapy.
    Duff C; Ballow M
    Immunol Allergy Clin North Am; 2020 Aug; 40(3):527-537. PubMed ID: 32654697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recovering autonomy is a key advantage of home-based immunoglobulin therapy in patients with myositis: A qualitative research study.
    Chérin P; Pindi Sala T; Clerson P; Dokhan A; Fardini Y; Duracinsky M; Crave JC; Chassany O
    Medicine (Baltimore); 2020 Feb; 99(7):e19012. PubMed ID: 32049796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of use of plasma immunoglobulins in therapeutics. The extension of indications needs controlled clinical studies].
    Habibi B
    Rev Prat; 1991 Dec; 41(25):2577-9. PubMed ID: 1803470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous gamma globulins].
    Gorostiza Felipe P
    An Esp Pediatr; 1989 Sep; 31 Suppl 38():109-13. PubMed ID: 2484994
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous immunoglobulin therapy for multifocal motor neuropathy.
    Eftimov F; Vermeulen M; de Haan RJ; van den Berg LH; van Schaik IN
    J Peripher Nerv Syst; 2009 Jun; 14(2):93-100. PubMed ID: 19691531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous immunoglobulin: facilitated infusion and advances in administration.
    Wasserman RL
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):75-7. PubMed ID: 25546770
    [No Abstract]   [Full Text] [Related]  

  • 8. Subcutaneous Immunoglobulin Therapy Prevents Systemic Capillary Leak Syndrome Attack.
    Scanvion Q; Lefèvre G; Hachulla E; Hatron PY; Lambert M
    Am J Med; 2016 Jul; 129(7):e77-8. PubMed ID: 27059380
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized trial of facilitated subcutaneous immunoglobulin in multifocal motor neuropathy.
    Al-Zuhairy A; Jakobsen J; Andersen H; Sindrup SH; Markvardsen LK
    Eur J Neurol; 2019 Oct; 26(10):1289-e82. PubMed ID: 31021036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of immunoglobulin preparations for intravenous use.
    Barandun S; Isliker H
    Vox Sang; 1986; 51(2):157-60. PubMed ID: 3535252
    [No Abstract]   [Full Text] [Related]  

  • 11. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.
    Lee DH; Linker RA; Paulus W; Schneider-Gold C; Chan A; Gold R
    Muscle Nerve; 2008 Mar; 37(3):406-9. PubMed ID: 17918749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment.
    Grunebaum E; Levy Y; Shoenfeld Y
    Isr Med Assoc J; 2002 Apr; 4(4):288-9. PubMed ID: 12001706
    [No Abstract]   [Full Text] [Related]  

  • 13. Survey of standards and guidelines for immunization delivery.
    Grabenstein JD
    Pharm Pract Manag Q; 2001; 20(3):60-72; quiz 73-6. PubMed ID: 11291519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European consensus proposal for immunoglobulin therapies.
    Sewell WA; Kerr J; Behr-Gross ME; Peter HH;
    Eur J Immunol; 2014 Aug; 44(8):2207-14. PubMed ID: 24975475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative immune globulin preparation when standard immune serum globulin is not available.
    Lutwick LI; Wu EH
    JAMA; 1991 Mar; 265(9):1114. PubMed ID: 1995995
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of subcutaneously administered immunoglobulin in myasthenia gravis: A systematic review.
    Adiao KJB; Espiritu AI; Roque VLA; Reyes JPBT
    J Clin Neurosci; 2020 Feb; 72():316-321. PubMed ID: 31493998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The ESID Online Database for primary immunodeficiencies. First analyses with regard to Germany and Europe].
    Knerr V; Gathmann B; Eades-Perner AM; Kindle G; Grimbacher B
    Med Klin (Munich); 2008 Sep; 103(9):620-7. PubMed ID: 18813884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical data on the use of intravenously administered gamma globulin produced by the Castacuzino Institute in different diseases of infectious etiology].
    Neguţ E; Litarczek G; Ghidaly M; Alexianu D; Dumitrescu A; Herlod A; Szégli G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(4):317-24. PubMed ID: 6084287
    [No Abstract]   [Full Text] [Related]  

  • 19. New uses for intravenous immune globulin.
    Stiehm ER
    N Engl J Med; 1991 Jul; 325(2):123-5. PubMed ID: 2052046
    [No Abstract]   [Full Text] [Related]  

  • 20. Summary of the NIH Consensus Conference on i.v. Immunoglobulins.
    Oncology (Williston Park); 1990 Dec; 4(12):12, 15. PubMed ID: 2149032
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.